Trippy Quotes

“I realized then that, beyond the body-convulsing tripping and the lure of the ritual, there’s a simple and perhaps paramount reason these retreats can be so healing. In these settings, we get to take on the pain of others, to share the burden of losses, big and small, of the regrets and the split-second horrors that diverted a person’s destiny. With that comes a realization that we are less alone than we presumed, less likely to be stigmatized than we feared, less atypical in our ambivalence about staying alive.”
― Ernesto Londoño, Trippy: The Peril and Promise of Medicinal Psychedelics

“It goes without saying that to outsiders—even enthusiasts of entheogenic plants—Santo Daime rituals can seem bizarre—cultish, even. Mindful of that, Daimistas, as a foundational rule, have long refrained from proselytizing. Newcomers who want to attend a ceremony are typically screened carefully to assess their state of mind and motivations. Many people who participate in Daime rituals for the first time never come back. Others warm up to its teachings and stoic traditions slowly. Then there are the instant converts, people like Alex Polari.”
― Ernesto Londoño, Trippy: The Peril and Promise of Medicinal Psychedelics

“Had ketamine been a new drug, pharmaceutical companies would have had a strong incentive to fund the kind of robust clinical trials federal regulators would have required to approve its use as a treatment for depression. But ketamine’s patent expired in 2002, which meant there was little to gain by bankrolling years of costly research.”
― Ernesto Londoño, Trippy: The Peril and Promise of Medicinal Psychedelics

“Among them was a seasoned psychiatrist who told Janis he had lost faith in the go-to intervention for depression. “I’ve been in an existential dilemma as a psychiatrist because I’m pained every time I write another script for Prozac or Zoloft,” Janis recalled the man saying. “I know it’s numbing out their symptoms, but it’s not getting to the heart of the matter.”
― Ernesto Londoño, Trippy: The Peril and Promise of Medicinal Psychedelics